EUZ.DE Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 май 2024 @ 18:37):

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide...

Stats
Объем за сегодня	49 457.00
Средний объем	59 242.00
Рыночная капитализация	820.97M
EPS	€0 ( 2024-03-21 )
Дата следующего отчета о доходах	( €0 ) 2024-05-13
Last Dividend	€0.500 ( 2023-06-08 )
Next Dividend	€0 ( N/A )
P/E	25.93
ATR14	€0.0550 (0.14%)

Объем Корреляция

Длинно: 0.25 (neutral)

Кратко: -0.03 (neutral)

Signal:(38.619) Neutral

Eckert & Ziegler Strahlen Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Eckert & Ziegler Strahlen Корреляция - Валюта/Сырье

-0.73
( moderate negative )

-0.51
( weak negative )

0.64
( weak )

-0.81
( strong negative )

0.36
( neutral )

0.56
( weak )

Eckert & Ziegler Strahlen Финансовые показатели

Annual	2023
Выручка:	€246.09M
Валовая прибыль:	€116.34M (47.28 %)
EPS:	€1.260

FY	2023
Выручка:	€246.09M
Валовая прибыль:	€116.34M (47.28 %)
EPS:	€1.260

FY	2022
Выручка:	€222.26M
Валовая прибыль:	€106.78M (48.04 %)
EPS:	€1.410

FY	2021
Выручка:	€180.44M
Валовая прибыль:	€91.08M (50.48 %)
EPS:	€1.670

Financial Reports:

No articles found.

Eckert & Ziegler Strahlen Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€0.500 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Eckert & Ziegler Strahlen Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.47 - Stable (10.56%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.113	2002-05-27
Last Dividend	€0.500	2023-06-08
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	21	--
Total Paid Out	€5.52	--
Avg. Dividend % Per Year	0.00%	--
Score	3.1	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.47
Div. Directional Score	7.98	--

Next Divdend (Est)
(2024-05-27)

€0.506 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

3.10

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
KTA.DE	Ex Dividend Junior	2023-05-30	Annually	0.00%
V6C.DE	Ex Dividend Junior	2023-06-01	Annually	0.00%
DR0.DE	Ex Dividend Junior	2023-06-30	Sporadic	0.00%
NKE.DE	Ex Dividend Knight	2023-09-01	Quarterly	0.00%
4PN.DE	Ex Dividend Knight	2023-06-22	Quarterly	0.00%
FMV.DE	Ex Dividend Junior	2023-08-15	Quarterly	0.00%
PSAN.DE	Ex Dividend Junior	2023-05-24	Sporadic	0.00%
AP2.DE	Ex Dividend Knight	2023-11-22	Quarterly	0.00%
HP3A.DE	Ex Dividend Junior	2023-06-21	Annually	0.00%
SOW.DE	Ex Dividend Junior	2023-05-18	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.107	1.500	7.86	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0599	1.200	8.00	9.61	[0 - 0.3]
returnOnEquityTTM	0.120	1.500	9.78	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.79	0.800	1.040	0.832	[1 - 3]
quickRatioTTM	2.31	0.800	1.089	0.871	[0.8 - 2.5]
cashRatioTTM	0.813	1.500	6.60	9.90	[0.2 - 2]
debtRatioTTM	0.128	-1.500	7.86	-10.00	[0 - 0.6]
interestCoverageTTM	11.64	1.000	6.80	6.80	[3 - 30]
operatingCashFlowPerShareTTM	2.28	2.00	9.24	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.015	2.00	9.49	10.00	[0 - 20]
debtEquityRatioTTM	0.253	-1.500	8.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.473	1.000	5.45	5.45	[0.2 - 0.8]
operatingProfitMarginTTM	0.189	1.000	8.22	8.22	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.842	1.000	6.43	6.43	[0.2 - 2]
assetTurnoverTTM	0.560	0.800	9.60	7.68	[0.5 - 2]
Total Score				11.48

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	30.36	1.000	7.03	0	[1 - 100]
returnOnEquityTTM	0.120	2.50	9.86	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.015	2.00	9.66	10.00	[0 - 30]
dividendYielPercentageTTM	1.303	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.28	2.00	9.24	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-8.12	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.193	1.000	7.69	0	[0.1 - 0.5]
Total Score				4.47

Eckert & Ziegler Strahlen

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.